Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8448557 | European Journal of Cancer | 2008 | 13 Pages |
Abstract
More studies are needed to investigate modifiable risk factors for endometrial cancer and endometrial hyperplasia. Existing therapies for endometrial hyperplasia target hormone imbalance, which is just one aspect of endometrial cancer development. Next generation therapies for endometrial cancer and endometrial hyperplasia patients should include diet, exercise and weight loss plans, which would target other modifiable aspects of endometrial cancer risk.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Faina Linkov, Robert Edwards, Judith Balk, Zoya Yurkovetsky, Barbara Stadterman, Anna Lokshin, Emanuela Taioli,